Source: Anadolu Agency

Myanmar confirms its first cases of COVID-19 yesterday (23 March), both of which were imported.

The country’s Health and Sports Ministry on Tue confirmed that the two cases are a 36-year-old Myanmar man — a US green card holder who had just returned from the said country — and a 26-year-old Myanmar man who had returned from England.

Both men, according to the ministry, had attempted to circumvent travel bans in the respective countries.

The Myanmar National Health Laboratory released its COVID-19 testing results on Mon, which will be sent to a WHO-accredited laboratory in Thailand today.

The patient who returned from the UK had arrived in Yangon on Sun. He was subsequently quarantined in Hlegu and subsequently moved to Hmawbi, where he tested positive for COVID-19. Currently, he is warded in a special isolation ward in Wabargyi Hospital. 

The patient who returned from the US arrived in Yangon on 13 Mar and experienced fever a week after. He is now placed under isolation at the Tedim township’s General Hospital in Chin State.

“We will investigate all the people who were in close contact with these two men,” said the Health Ministry.

Myanmar Times reported today that people had rushed to supermarkets and convenience stores to buy food and other supplies around an hour after the Health Ministry’s announcement.
Subscribe
Notify of
1 Comment
Newest
Oldest Most Voted
Inline Feedbacks
View all comments
You May Also Like

印度司法程序严重延宕 新印商贸关系是否应更谨慎?

日前,《彭博社》于周二发表一篇文章,强调在印度做生意是多么困难,尤其是他们臭名昭著的司法程序,更是出了名的延宕。这样的延宕严重影响了企业的发展,甚至是损毁了双方的交易。 到底印度在司法程序上,其延宕程度到什么地步?印度最高法院最近颁布一项裁决,也揭示了其严重的延宕程度。一个于1982年将涉嫌伪造姜黄的案件,竟然拖至38年后才完成所有的司法程序,更离奇的是,最终仅被判一个月监禁和500元卢比(约6.70元新币)的罚款。 据了解,该案件在十年后,最高法院撤销了被告的定罪,而且两个下级法院花了约14年的时间才作出判决。 尽管该案看似相当离谱的司法程序,但它也非特别案例。目前印度的三级司法系统中,有近4千万个案件仍在待审中。而在印度的25个邦中的各个高级法院,已有逾17万3千个案例已超过20年,即每个州属平均可能将会有7千宗案例是逾20年以上的待审案件。甚至有近一半的案件已待定逾30年,这还不包括少于20年的待定案件。 印度也被世界银行列为倒数第15位,比巴基斯坦、叙利亚和塞内加尔还要糟糕。若没有一个良好有效的法律制度监督合同的进行,合同的法律效益等于无效,而且当有人违反合同时,也无法即时得到反响。 印度的延宕臭名昭彰,为何我国仍坚决加入CECA? 长期的司法延宕让印度最大的公司趁虚而入,完成许多大规模的交易,如综合健保控股(IHH Healthcare)试图取代印度富通医疗服务集团(Fortis Healthcare Ltd),却因日本制药公司第一三共株式会社(Daiichi Sankyo)申请的庭令而遇阻。 第一三共和富通保健的创办人辛格兄弟对簿公堂,印度最高法院下令IHH暂缓收购交易。辛格兄弟当时也接受印度当局的欺诈调查。…

AHPETC fined $800 for holding trade fair without approval from NEA

Aljunied-Hougang-Punggol East Town Council (AHPETC) has been fined $800 by the courts…